北美化疗引起的周围神经病变市场预测至 2028 年 – COVID-19 影响和区域分析 – 药物类别（类固醇、抗抑郁药、蚂蚁癫痫和麻醉药）和分销渠道（零售药房、医院药房和在线药房）
No. of Pages: 99 | Report Code: BMIRE00025644 | Category: Life Sciences
No. of Pages: 99 | Report Code: BMIRE00025644 | Category: Life Sciences
癌症每年导致该地区数百万人死亡今年，尽管医学取得了长足进步，但仍需要解决许多长期存在的问题以改善癌症治疗。因此，肿瘤学研究小组致力于寻找新的有效治疗方法，以减少传统治疗的主要副作用。 2021年4月，致力于开发Halneuron治疗慢性疼痛的生物技术公司WEX Pharmaceuticals Inc.在Toxins Journal特刊上发表了两项关于河豚毒素（TTX）作为治疗剂的临床研究。 2020 年 3 月，Senzer Pharmaceuticals 为其前美国战略合作伙伴为其正在进行的 FDA 注册计划获得了研究新药 (IND) 申请和数据包，以获得批准其大麻素呼吸装置用于治疗抗癌引起的副作用药物。 2020年2月，私营生物技术公司NoNo Inc.报道了一种名为nerinetide的新型肽，无需事先服用阿替普酶。在一项多中心、随机研究中，这证明了急性缺血性中风患者的重要临床改善。这些新产品的开发和推出可能会在未来几年为化疗引起的周围神经病变市场带来新趋势。
通过提供具有新功能的产品和服务和技术，北美化疗引起的周围神经病变市场的供应商可以吸引更大的客户群并扩大他们在新兴市场的足迹。这一因素可能会在预测期内推动市场实现大幅复合年增长率。
图表：北美化疗引起的周围神经病变到 2028 年的市场收入和预测（十亿美元）
< /p>
北美化疗引起的周围神经病变市场细分
北美化疗引起的周围神经病变市场根据药物类别、分销渠道、和国家。根据药物类别，市场分为类固醇药、抗癫痫药、麻醉药和抗抑郁药。 2021年，类固醇细分市场占据最大市场份额，预计抗癫痫药物在预测期内的复合年增长率最高。根据分销渠道，北美化疗引起的周围神经病变市场分为医院药房、零售药房和网上药房。 2021年，医院药房细分市场占据最大市场份额，零售药房细分市场预计在预测期内实现最高的复合年增长率。根据国家/地区，北美化疗引起的周围神经病变市场分为美国、加拿大和墨西哥。 2021年，美国占据最大的市场份额，预计在预测期内将创下最快的复合年增长率。
REGENACY PHARMACEUTICALS, INC.；旭化成制药公司； Novaremed 股份公司； MAKScientific 有限责任公司； WEX 制药公司；索瓦制药公司；基内塔公司； Aptinyx 公司； Apexian 制药公司；和 WinSanTor, Inc. 是北美化疗引起的周围神经病变市场的领先公司。
Strategic insights for North America Chemotherapy Induced Peripheral Neuropathy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 297.89 Billion |
| Market Size by 2028 | US$ 426.71 Billion |
| Global CAGR (2021 - 2028) | 5.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物类别
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Chemotherapy Induced Peripheral Neuropathy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Chemotherapy Induced Peripheral Neuropathy Market is valued at US$ 297.89 Billion in 2021, it is projected to reach US$ 426.71 Billion by 2028.
As per our report North America Chemotherapy Induced Peripheral Neuropathy Market, the market size is valued at US$ 297.89 Billion in 2021, projecting it to reach US$ 426.71 Billion by 2028. This translates to a CAGR of approximately 5.3% during the forecast period.
The North America Chemotherapy Induced Peripheral Neuropathy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Chemotherapy Induced Peripheral Neuropathy Market report:
The North America Chemotherapy Induced Peripheral Neuropathy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Chemotherapy Induced Peripheral Neuropathy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Chemotherapy Induced Peripheral Neuropathy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Chemotherapy Induced Peripheral Neuropathy Market
